GeneDx Holdings Corp

WGS

Company Profile

  • Business description

    GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

  • Contact

    333 Ludlow Street
    North Tower, 6th Floor
    StamfordCT06902
    USA

    T: +1 888 729-1206

    https://www.genedx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    1,300

Stocks News & Analysis

stocks

Is SpaceX a threat to this ASX giant?

Investors are raising concerns about the future of telecommunication connectivity in Australia.
stocks

Chart of the Week: This ASX top pick might be overlooked

ASX top pick remains cheap as investor concerns around wage costs might be overdone.
stocks

ASX share undervalued as margins expected to rebound

This ASX share remains overlooked despite a strong outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,126.8039.10-0.43%
CAC 408,467.9837.190.44%
DAX 4025,026.8092.130.37%
Dow JONES (US)51,564.7072.150.14%
FTSE 10010,399.70108.91-1.04%
HKSE23,924.81387.35-1.59%
NASDAQ26,517.93496.281.91%
Nikkei 22571,053.491,151.241.65%
NZX 50 Index13,383.6420.330.15%
S&P 5007,500.5880.481.08%
S&P/ASX 2008,911.1037.60-0.42%
SSE Composite Index4,090.4817.59-0.43%

Market Movers